Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.
Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.